Correlation of benefit from immune checkpoint inhibitors with next gen sequencing (NGS) profiles in esophagogastric cancer (EGC) patients Meeting Abstract

  

Authors:	Ku, G. Y.; Sanchez-Vega, F.; Chatila, W.; Margolis, M.; Fein, C.; Ilson, D. H.; Hechtman, J. F.; Tuvy, Y.; Bouvier, N.; Kundra, R.; Shia, J.; Heins, Z. J.; Middha, S.; Zehir, A.; Ladanyi, M.; Berger, M. F.; Tang, L. H.; Solit, D. B.; Schultz, N.; Janjigian, Y. Y.
Abstract Title:	Correlation of benefit from immune checkpoint inhibitors with next gen sequencing (NGS) profiles in esophagogastric cancer (EGC) patients
Meeting Title:	53rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	35
Issue:	15 Suppl.
Meeting Dates:	2017 Jun 2-6
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2017-05-20
Start Page:	205s
Language:	English
ACCESSION:	WOS:000411895708109
DOI:	10.1200/JCO.2017.35.15_suppl.4025
PROVIDER:	wos
Notes:	Meeting Abstract: 4025 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/147189